Hexagon Nutrition working capital

·Pharma & HealthChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendFY26Mar 2026
153.47×
77.95×
52.67×
178.75×
2.25×
1.20×
0.16×
0.12×
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

HEXAGON₹57.32

Hexagon Nutrition Limited

· Pharma & Health
₹ CroreMcap ₹634 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY26
31/03/2026
Inventory Days (DIO)153.47
Receivable Days (DSO)77.95
Payable Days (DPO)52.67
Cash Conversion Cycle (days)178.75
Working Capital Turnover2.25
Asset Turnover1.20
Cash Conversion (CFO/Net Income)0.16
CFO/EBITDA0.12
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.